Overview

Gemigliptin, Dapagliflozin, Empagliflozin DDI Study

Status:
Unknown status
Trial end date:
2018-12-22
Target enrollment:
Participant gender:
Summary
gemigliptin,SGLT-2i DDI study
Phase:
Phase 1
Details
Lead Sponsor:
LG Chem
Treatments:
Dapagliflozin
Empagliflozin